A detailed history of Franklin Resources Inc transactions in Novavax Inc stock. As of the latest transaction made, Franklin Resources Inc holds 97,162 shares of NVAX stock, worth $845,309. This represents 0.0% of its overall portfolio holdings.

Number of Shares
97,162
Previous 97,162 -0.0%
Holding current value
$845,309
Previous $1.23 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$10.71 - $17.11 $780,694 - $1.25 Million
72,894 Added 300.37%
97,162 $1.23 Million
Q2 2024

Aug 14, 2024

BUY
$3.89 - $20.97 $1,054 - $5,682
271 Added 1.13%
24,268 $307,000
Q1 2024

May 13, 2024

BUY
$3.76 - $6.02 $1,289 - $2,064
343 Added 1.45%
23,997 $114,000
Q4 2023

Feb 09, 2024

SELL
$4.8 - $7.67 $878 - $1,403
-183 Reduced 0.77%
23,654 $113,000
Q3 2023

Nov 13, 2023

BUY
$6.81 - $9.74 $1,695 - $2,425
249 Added 1.06%
23,837 $172,000
Q2 2023

Aug 11, 2023

BUY
$6.67 - $9.52 $157,331 - $224,557
23,588 New
23,588 $175,000
Q4 2022

Feb 10, 2023

SELL
$8.86 - $25.04 $14,158 - $40,013
-1,598 Reduced 0.86%
184,551 $1.9 Million
Q3 2022

Nov 14, 2022

SELL
$18.2 - $76.12 $905,195 - $3.79 Million
-49,736 Reduced 21.08%
186,149 $3.39 Million
Q2 2022

Aug 11, 2022

SELL
$36.28 - $75.29 $62,655 - $130,025
-1,727 Reduced 0.73%
235,885 $12.1 Million
Q1 2022

May 13, 2022

SELL
$69.73 - $142.9 $25.9 Million - $53 Million
-370,872 Reduced 60.95%
237,612 $17.5 Million
Q4 2021

Feb 11, 2022

SELL
$134.56 - $217.97 $62.4 Million - $101 Million
-464,064 Reduced 43.27%
608,484 $87.1 Million
Q3 2021

Nov 12, 2021

SELL
$177.8 - $270.58 $4.82 Million - $7.34 Million
-27,114 Reduced 2.47%
1,072,548 $222 Million
Q2 2021

Aug 13, 2021

SELL
$121.0 - $257.67 $24.9 Million - $53 Million
-205,748 Reduced 15.76%
1,099,662 $233 Million
Q1 2021

May 13, 2021

BUY
$112.98 - $319.93 $3.06 Million - $8.68 Million
27,121 Added 2.12%
1,305,410 $237 Million
Q4 2020

Feb 10, 2021

SELL
$78.74 - $139.5 $76.3 Million - $135 Million
-969,382 Reduced 43.13%
1,278,289 $143 Million
Q3 2020

Nov 12, 2020

SELL
$79.44 - $178.51 $61.1 Million - $137 Million
-768,753 Reduced 25.49%
2,247,671 $244 Million
Q2 2020

Aug 13, 2020

BUY
$13.86 - $83.61 $17.9 Million - $108 Million
1,290,399 Added 74.76%
3,016,424 $442 Million
Q1 2020

May 13, 2020

BUY
$3.93 - $16.0 $6.78 Million - $27.6 Million
1,726,025 New
1,726,025 $23.4 Million

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $680M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.